Trademark Search  /  CRISPR THERAPEUTICS

CRISPR THERAPEUTICS

● Live · Registered

U.S. federal trademark · Serial No. 90715256 · Reg. No. 6724517

Mark
CRISPR THERAPEUTICS
Status
Registered
Serial Number
90715256
Registration No.
6724517
Filing Date
May 17, 2021
Registration Date
May 24, 2022
Class(es)
Class 041, Class 042

Owners

CRISPR Therapeutics AG
99 · ZUG V8, CH
CRISPR Therapeutics AG
99 · ZUG V8, CH
CRISPR Therapeutics AG
99 · ZUG V8, CH

Goods & Services

Education services, namely, providing on-line non-downloadable articles and newsletters in the field of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy

Scientific research and development, namely, gene editing for researching and developing human cells and pharmaceuticals; research and development of therapeutics pharmaceuticals using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical laboratory services; scientific laboratory services; custom cell-line engineering services; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting genetic therapies to individuals

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "CRISPR THERAPEUTICS" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.